Neoadjuvant Chemotherapy: The Debate Continues

Two articles in the Journal of Clinical Oncology debate the use of neoadjuvant chemotherapy – chemo given before surgery – for ovarian cancer patients.

Based on some studies, researchers conclude that neoadjuvant chemotherapy may be the best option for some patients. However, other researchers conclude that aggressive optimal debulking surgery is the best path for patients.